Test Dose Pharmacokinetics in Pediatric Patients Receiving Once‐Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?

Publisher： John Wiley & Sons Inc

E-ISSN： 1552-4604|58|3|332-339

ISSN： 0091-2700

Source： JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.58, Iss.3, 2018-03, pp. : 332-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical comparison of weight‐ and age‐based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 3, 2015-05 ,pp. : 307-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long‐term voriconazole

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 5, 2015-05 ,pp. : 918-920

John Wiley & Sons Inc

Access to resources Recommend Favorite

The yield of monitoring for HSV and VZV viremia in pediatric hematopoietic stem cell transplant patients

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 6, 2015-09 ,pp. : 640-644

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐total body irradiation myeloablative conditioning with intravenous busulfan and cyclophosphamide in hematopoietic stem cell transplantation for malignant infantile osteopetrosis

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 4, 2015-06 ,pp. : 422-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of Busulfan and Cyclophosphamide Conditioning with Sleep Disorders after Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 124, Iss. 2, 2010-09 ,pp. : 125-128

Karger

Access to resources Recommend Favorite